BioSpace News Archive

Today, Biotricity highlighted several of its major operating achievements since fiscal year 2022.

Revance Therapeutics, Inc. (RVNC), today announced that the company will participate in the following investor conferences.

Artax Biopharma, Inc. today announces the Company has appointed Andre Hoekema, Ph.D., to the Company’s Board of Directors.

Sofwave Medical Ltd today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will provide a corporate update and participate in one-on-one investor meetings at the Oppenheimer 33rd Annual Healthcare Conference, to be held virtually from March 13-15, 2023.

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”) today announced that the previously reported results from the final analysis of a Phase 1 clinical trial of the combination of galinpepimut-S (GPS) with the anti-PD-1 antibody nivolumab (Opdivo®) in patients with relapsed WT1-expressing ovarian cancers (NCT02737787) have been published in the peer-reviewed journal Cancers.

TC BioPharm today announced that the company has taken steps to focus its clinical strategy on the planned future FDA trials for TCB-008 in AML as a monotherapy and other oncology indications in combination with additional assets.

MiNK Therapeutics, Inc. (NASDAQ: INKT) today announced that the Company will release its fourth quarter and full year 2022 financial results before the market opens on Tuesday, March 21, 2023.

Abbott (NYSE: ABT) has received U.S. Food and Drug Administration clearance for what will be the first commercially available laboratory traumatic brain injury (TBI) blood test, making it widely available to hospitals in the United States.

Cyclacel Pharmaceuticals, Inc. announced today that the Company plans to participate in a fireside chat and host one-on-one meetings at two investor conferences.

Nucleus Biologics and Stoic Bio have announced plans for a supply agreement with the Center for Breakthrough Medicines, a leading contract development and manufacturing organization, whose mission is to save lives by accelerating the development and manufacture of advanced therapies.